Office of the Chief Scientist
VC Fund
Tel Aviv, Israel
Office of the Chief Scientist is a VC fund in Tel Aviv focused on Health Care and Biotechnology. The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 39%
Last updated:
For AI agents: llms.txt
Industries Office of the Chief Scientist invests in
Stages Office of the Chief Scientist invests in
Countries Office of the Chief Scientist invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $50k–$1.6M
- Grant
- $27k–$1.3M
- Non-Equity Assistance
- $155k–$1.5M
Investment Focus
Industry
- Health Care 8 (44%)
- Biotechnology 4 (22%)
- Medical Device 3 (17%)
- AgTech 2 (11%)
- Medical 2 (11%)
Stage
- Grant 7 (39%)
- Seed 6 (33%)
- Non-equity Assistance 2 (11%)
Country
- Israel 14 (78%)
- United States 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Avi Luvton
Executive Director, Asia Pacific Desk, Business Development
|
Executive Director, Asia Pacific Desk, Business Development | Total investments: 0 | Find email | |
|
Haya Miller
Deputy Managing Director
|
Deputy Managing Director | Total investments: 0 | Find email | |
Israel Shamay
Executive Director, Strategic Initiatives, Head of the Americas Operations
|
Executive Director, Strategic Initiatives, Head of the Americas Operations | Total investments: 0 | Find email | |
|
Michel Hiver
Deputy Managing Director
|
Deputy Managing Director | Total investments: 0 | Find email | |
|
Moshe Avrahami
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hargol™ FoodTech
|
Hargol™ FoodTech is the world's first commercial grasshopper farm! Grasshoppers are nature's most efficient protein source.Hargol™ FoodTech revolutionize the protein ingredient industry by providing a healthier and more sustainable and affordable alternative, becoming the leading intensive rearing company of grasshoppers in the world.The company is at the forefront of high quality nutrients and healthy grasshoppers supply to markets around the world, improving current market wild-harvested supply by providing year-round availability, nutrients content & quality and costs reduction.For its first line of products, Hargol FoodTech relies on methods and technologies of intensive breeding and growing of three grasshopper species that are processed into protein powders. The company is offering grasshopper based protein ingredient in North America markets to food/ingredient manufacturers and whole grasshoppers.Hargol™ FoodTech have thus far been attracting the interest of food producers, distributors and retailers in the North America, Europe and other regions of the world with whole grasshoppers, grasshopper’s nutrient-rich powder and innovative food products.With the expected 70% rise in demand for animal source protein over the next decades and with existing animal source protein taking a big toll on the environment there is a need for an alternative – Both sustainable and affordable for populations around the globe.Enhanced by their vegetarian diet grasshoppers’ nutrient content is superior compare to other insects or animal source protein: Over 70% whole protein, Omega-3 & Omega-6, Zinc, Iron, & Folic acid. Grasshoppers are also the only Kosher and Halal insect in the world! | $120K / Grant / Mar 07, 2019 | |
|
Hargol™ FoodTech
|
Hargol™ FoodTech is the world's first commercial grasshopper farm! Grasshoppers are nature's most efficient protein source.Hargol™ FoodTech revolutionize the protein ingredient industry by providing a healthier and more sustainable and affordable alternative, becoming the leading intensive rearing company of grasshoppers in the world.The company is at the forefront of high quality nutrients and healthy grasshoppers supply to markets around the world, improving current market wild-harvested supply by providing year-round availability, nutrients content & quality and costs reduction.For its first line of products, Hargol FoodTech relies on methods and technologies of intensive breeding and growing of three grasshopper species that are processed into protein powders. The company is offering grasshopper based protein ingredient in North America markets to food/ingredient manufacturers and whole grasshoppers.Hargol™ FoodTech have thus far been attracting the interest of food producers, distributors and retailers in the North America, Europe and other regions of the world with whole grasshoppers, grasshopper’s nutrient-rich powder and innovative food products.With the expected 70% rise in demand for animal source protein over the next decades and with existing animal source protein taking a big toll on the environment there is a need for an alternative – Both sustainable and affordable for populations around the globe.Enhanced by their vegetarian diet grasshoppers’ nutrient content is superior compare to other insects or animal source protein: Over 70% whole protein, Omega-3 & Omega-6, Zinc, Iron, & Folic acid. Grasshoppers are also the only Kosher and Halal insect in the world! | $80K / Grant / Feb 15, 2019 | |
GalaPro
|
GalaPro offers an Award winning app that provides Real-time Synchronized Subtitles, Dubbing & Amplification for Theater Shows, Movies, Museums & Conferences using Artificial intelligence and Machine learning. GalaPro was founded by Dr. Elena Litsyn and Hagai Pipko in July 2015. It is based in Herzliya, Israel and New York City | $1M / Grant / Jan 01, 2019 | |
|
GalaPro
|
GalaPro offers an Award winning app that provides Real-time Synchronized Subtitles, Dubbing & Amplification for Theater Shows, Movies, Museums & Conferences using Artificial intelligence and Machine learning. GalaPro was founded by Dr. Elena Litsyn and Hagai Pipko in July 2015. It is based in Herzliya, Israel and New York City | $1M / Grant / Jan 01, 2018 | |
|
GalaPro
|
GalaPro offers an Award winning app that provides Real-time Synchronized Subtitles, Dubbing & Amplification for Theater Shows, Movies, Museums & Conferences using Artificial intelligence and Machine learning. GalaPro was founded by Dr. Elena Litsyn and Hagai Pipko in July 2015. It is based in Herzliya, Israel and New York City | $1M / Grant / Jan 01, 2017 | |
Magentiq Eye Ltd
|
Magentiq Eye Ltd. was established in 2014 with the aim to harness the most cutting edge computer vision and deep learning techniques to aid doctors in endoscopic procedures. Doctors today spend hours during Endoscopic Procedures looking at the LCD screens in order to explore, examine and treat various conditions. At Magentiq Eye we put the growingpower of Deep Learning, Image and Video Processing to the help of doctors, so they can be more accurate and effective- ultimately saving millions of lives and billions of dollars. Our first product is APDS: Automatic Polyp Detection System, developed to be used in online and offline colonoscopies. Our APDS (Automatic Polyp Detection System) can point out the suspicious locations of polyps in the videos, increasing the attentiveness of doctors during procedures, thus helping them to reduce their polyp miss-rates. Given the large population that annually undergoes colonoscopy, even a modest decrease in polyp miss-rate can save a lot of lives! The APDS- RT runs on the video feed from the endoscopic camera used by the physician in real time during the endoscopic procedure (currently only on Colonoscopy Procedure). The APDS-OFL is a software that runs in off-line mode on pre-Recorded Colonoscopy Videos. It is estimated that 40 million colonoscopy procedures are performed every year (almost 40% in the US alone). The ability of colonoscopy procedures to decrease the number of colon cancer cases has been proven without a doubt and their number expected to grow. However, researches have shown that there is about 25% of misses (undetected polyps) in those procedures, misses which can, unfortunately, cause interval cancer. Within this context The APDS can be sold as an add-on to the colonoscopy system or as a service (license per exam), paid by the clinic or hospital. Once the APDS system would be formally proven, during the next year, to improve polyp detection rate, it could be sold either jointly with the endoscopic equipment providers or it can be integrated in the colonoscopy devices. | $155K / Non-equity Assistance / Jan 01, 2017 | |
Check-Cap
|
Check-Cap is a young and dynamic medical device company with breakthrough solution for Colorectal Cancer Screening. The Check-Cap device requires no bowel preparation or invasive procedures, and is expected to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy. | $1.3M / Grant / Aug 02, 2016 | |
Inspecto Solutions
|
Today's technology such as HPLC/GC for detecting food contaminants is limited by size, cost and complexity to operate. Therefore it is restricted to the lab and only samples of food across the supply-chain are being checked in he process. Inspecto's basic value proposition offers all players in the food industry the capability tocheck for early signs of contaminants in minutes and at a fraction of the cost, enabling large volumes of scans. The data is cloud stored and integrated with Blockchain for data safety and advanced data analysis aimed to improve our customers' business performance based on traceability and quality assurance. | $27K / Grant / Aug 01, 2016 | |
DiA Imaging Analysis
|
DiA Imaging Analysis provides advanced AI-based ultrasound analysis smarter and accessible. It solves the two main challenges clinicians face when using ultrasound: acquiring the right image and automatically analyzing it, to find clinical abnormalities that today they are struggling to find visually. DiA's automated tools can be easily beadded to any ultrasound device or healthcare IT system, just like an App.The company holds FDA/CE Clearances for its cardiac toolbox, generating revenues and having thousands of users around the world. | $1.5M / Non-equity Assistance / Aug 01, 2016 | |
knil
|
Knil is the new way to make the most out of the web. Knil is web curator engine that gathers, structures and selects the most interesting information from all over the web for you. | $1.2M / Grant / Apr 19, 2016 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Office of the Chief Scientist invest in?
Office of the Chief Scientist invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Grant and Seed stage. Most of the 18 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Office of the Chief Scientist's check size?
Office of the Chief Scientist typically joins rounds of $50k–$1.6M at Seed, $27k–$1.3M at Grant and $155k–$1.5M at Non-Equity Assistance. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Office of the Chief Scientist participates in.
How do I contact Office of the Chief Scientist?
Public channels for Office of the Chief Scientist include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Office of the Chief Scientist?
The team at Office of the Chief Scientist includes Avi Luvton (Executive Director, Asia Pacific Desk, Business Development), Haya Miller (Deputy Managing Director) and Israel Shamay (Executive Director, Strategic Initiatives, Head of the Americas Operations), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
